Vaccination research : open journal最新文献

筛选
英文 中文
Current Status of Human Immunodeficiency Virus Vaccines 人类免疫缺陷病毒疫苗的现状
Vaccination research : open journal Pub Date : 2016-12-31 DOI: 10.17140/vroj-1-e002
D. Sosa, R. Jayant, A. Kaushik, M. Nair
{"title":"Current Status of Human Immunodeficiency Virus Vaccines","authors":"D. Sosa, R. Jayant, A. Kaushik, M. Nair","doi":"10.17140/vroj-1-e002","DOIUrl":"https://doi.org/10.17140/vroj-1-e002","url":null,"abstract":"Highly Active Antiretroviral Therapies (HAARTs) have been developed to treat HIV+ individuals, increasing the quality and quantity of life of many HIV+ patients. Despite these effective strategies, human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) epidemic continues to uphold globally with 39 million infected individuals.","PeriodicalId":93237,"journal":{"name":"Vaccination research : open journal","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83654392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Leading Ebola Vaccine Candidates 领先的埃博拉候选疫苗
Vaccination research : open journal Pub Date : 2016-12-31 DOI: 10.17140/vroj-1-101
V. Pavot
{"title":"Leading Ebola Vaccine Candidates","authors":"V. Pavot","doi":"10.17140/vroj-1-101","DOIUrl":"https://doi.org/10.17140/vroj-1-101","url":null,"abstract":"The ongoing outbreak of Ebola Virus Disease (EVD) in West Africa is the largest outbreak ever recorded with a total number of 28,602 confirmed, probable, or suspected cases in Guinea, Liberia, and Sierra Leone, including 11,301 reported deaths since December 2013 (as of January 17, 2016).1 A meeting convened by the World Health Organization (WHO) in September, 2014, concluded that an urgent unmet need exists for efficacy and safety testing of the EVD vaccine candidates and that clinical trials should be expedited. These vaccines could be used both in an outbreak setting and to provide long-term protection in populations at risk of sporadic outbreaks.","PeriodicalId":93237,"journal":{"name":"Vaccination research : open journal","volume":"34 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90534741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Dendritic Cell Maturation is a Critical Step in Dendritic Cell Vaccine Preparation for Cancer Therapy 树突状细胞成熟是制备用于癌症治疗的树突状细胞疫苗的关键步骤
Vaccination research : open journal Pub Date : 2016-12-31 DOI: 10.17140/vroj-1-105
S. Farashi-Bonab, N. Khansari
{"title":"Dendritic Cell Maturation is a Critical Step in Dendritic Cell Vaccine Preparation for Cancer Therapy","authors":"S. Farashi-Bonab, N. Khansari","doi":"10.17140/vroj-1-105","DOIUrl":"https://doi.org/10.17140/vroj-1-105","url":null,"abstract":"Background: Dendritic cell (DC) vaccine is a hopeful approach for cancer treatment. In clinical trials, DC vaccines have produced clinical responses in some cancer patients. However, DC vaccines efficacy is not satisfactory in most types of cancer and more efforts must be done to improve their effectiveness in advanced cancers. Understanding the influence of tumor cells and tumor stromal cells on DCs and the antitumor activity of ex vivo generated DCs in the tumor microenvironment can help to augment antitumor efficiency of ex vivo generated DCs. In a fibrosarcoma tumor model, we explored effects of the tumor microenvironment on the antitumor efficacy of ex vivo generated DCs. Methods: DCs were generated from mouse bone marrow precursor cells in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4). DCs were pulsed with tumor antigens and matured in the presence of tumor necrosis factor-alpha (TNF-α), lipopolysaccharide (LPS), or TNF-α plus LPS. Mature or immature DCs were injected subcutaneously before tumor inoculation or were directly injected into the tumor tissue. Results: Tumor antigen-pulsed DCs matured in the presence of TNF-α plus LPS showed appropriate functionality in vitro, including IL-12 secretion and induction of lymphocyte proliferation. Tumor lysate-loaded DCs matured in the presence of TNF-α did not show appropriate antitumor function in vivo. Injection of antigen-unpulsed mature DCs two days before tumor inoculation resulted in antitumor effects. In contrast, injection of immature DCs directly into the tumor tissue enhanced the tumor growth. Conclusion: These results suggest that tumor cells, tumor stromal cells, or tumor derived factors can influence DCs to have tumor-promoting function. Appropriate maturation induction in ex vivo generated DCs and manipulating the tumor microenvironment before DC vaccination may improve antitumor activity of DC vaccines in cancer patients.","PeriodicalId":93237,"journal":{"name":"Vaccination research : open journal","volume":"50 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83261943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
C-C Chemokine Receptor Seven (CCR7): Coming of Age In Vaccines. C-C趋化因子受体7 (CCR7):疫苗的成熟
Vaccination research : open journal Pub Date : 2016-04-01
Colin A Bill, Olga B Soto, Charlotte M Vines
{"title":"C-C Chemokine Receptor Seven (CCR7): Coming of Age In Vaccines.","authors":"Colin A Bill, Olga B Soto, Charlotte M Vines","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":93237,"journal":{"name":"Vaccination research : open journal","volume":"1 1","pages":"7-9"},"PeriodicalIF":0.0,"publicationDate":"2016-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ff/6b/nihms-1657348.PMC7839828.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38874127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
C-C Chemokine Receptor Seven (CCR7): Coming of Age In Vaccines C-C趋化因子受体7 (CCR7):疫苗的成熟
Vaccination research : open journal Pub Date : 2016-04-01 DOI: 10.17140/vroj-1-102
C. A. Bill, Olga B Soto, C. Vines
{"title":"C-C Chemokine Receptor Seven (CCR7): Coming of Age In Vaccines","authors":"C. A. Bill, Olga B Soto, C. Vines","doi":"10.17140/vroj-1-102","DOIUrl":"https://doi.org/10.17140/vroj-1-102","url":null,"abstract":"In casual conversation with non-medical individuals, it is common for them to ask: why do we not have a cure for cancer or vaccinations for all diseases? It seems somewhat logical to assume that after so many years of research that cures should be readily available, diseases in general should simply require a pill or jab and that somehow, if scientists are not deliberately hiding these cures, then they must be asleep at the wheel. A typical response to such questions focuses on the complexity of the different cancers/diseases and that there will be no “one cure fits all”. When it comes to vaccinations, there is absolutely no doubt that many vaccines are extremely effective and a multitude of publications can attest to this and cite how many lives have been saved because of our vaccination programs; indeed, vaccinations typically pop up on a list of reasons why humans today are living substantially longer than at any previous time in history.1-3 Nevertheless, there is always an overriding and to some extent embarrassing realization that despite the relative success of vaccines we still do not, for the most part, know how to make consistently effective vaccines and that often it boils down to a trial and error procedure to establish the best vaccine for a given target","PeriodicalId":93237,"journal":{"name":"Vaccination research : open journal","volume":"36 1","pages":"7 - 9"},"PeriodicalIF":0.0,"publicationDate":"2016-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87549825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovations in Microbial Biodiscovery, Targeting Silent Metabolism and New Chemical Diversity 微生物发现的创新,针对沉默代谢和新的化学多样性
Vaccination research : open journal Pub Date : 2013-07-17 DOI: 10.14264/UQL.2017.734
Zeinab G. Khalil
{"title":"Innovations in Microbial Biodiscovery, Targeting Silent Metabolism and New Chemical Diversity","authors":"Zeinab G. Khalil","doi":"10.14264/UQL.2017.734","DOIUrl":"https://doi.org/10.14264/UQL.2017.734","url":null,"abstract":"It is quite evident that microbial (bacteria or fungi) crude extracts contain several important bioactive compounds and some have already shown their therapeutic activity. Unfortunately, most of the compounds have not properly been evaluated for the exploration of new lead molecule. Moreover, some of the mechanisms of actions of few bioactive compounds have not been identified so far. Hence, extensive research is required to find out the activity of compounds in the microbial crude extracts and to exploit their therapeutic potential to unlock silent secondary metabolites. Therefore, this review article raise the importance of activating microbial secondary metabolites noting the need for new tools to access the full microbial genome","PeriodicalId":93237,"journal":{"name":"Vaccination research : open journal","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2013-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84093156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信